Arbutus Biopharma Corp Stock Market Value
| ABUS Stock | USD 3.42 0.09 2.56% |
| Symbol | Arbutus |
Arbutus Biopharma Corp Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arbutus Biopharma. If investors know Arbutus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arbutus Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.43) | Revenue Per Share 0.037 | Quarterly Revenue Growth (0.71) | Return On Assets (0.33) | Return On Equity (0.68) |
The market value of Arbutus Biopharma Corp is measured differently than its book value, which is the value of Arbutus that is recorded on the company's balance sheet. Investors also form their own opinion of Arbutus Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Arbutus Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arbutus Biopharma's market value can be influenced by many factors that don't directly affect Arbutus Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arbutus Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Arbutus Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arbutus Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Arbutus Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arbutus Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arbutus Biopharma.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Arbutus Biopharma on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Arbutus Biopharma Corp or generate 0.0% return on investment in Arbutus Biopharma over 30 days. Arbutus Biopharma is related to or competes with ADMA Biologics, Adaptimmune Therapeutics, Affimed NV, and Corvus Pharmaceuticals. Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus in... More
Arbutus Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arbutus Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arbutus Biopharma Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 15.75 | |||
| Value At Risk | (4.23) | |||
| Potential Upside | 3.1 |
Arbutus Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arbutus Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arbutus Biopharma's standard deviation. In reality, there are many statistical measures that can use Arbutus Biopharma historical prices to predict the future Arbutus Biopharma's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (1.14) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arbutus Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Arbutus Biopharma Corp Backtested Returns
Arbutus Biopharma Corp secures Sharpe Ratio (or Efficiency) of -0.0605, which signifies that the company had a -0.0605% return per unit of standard deviation over the last 3 months. Arbutus Biopharma Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arbutus Biopharma's mean deviation of 1.77, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0912, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Arbutus Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Arbutus Biopharma is expected to be smaller as well. At this point, Arbutus Biopharma Corp has a negative expected return of -0.16%. Please make sure to confirm Arbutus Biopharma's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Arbutus Biopharma Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.70 |
Good predictability
Arbutus Biopharma Corp has good predictability. Overlapping area represents the amount of predictability between Arbutus Biopharma time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arbutus Biopharma Corp price movement. The serial correlation of 0.7 indicates that around 70.0% of current Arbutus Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.7 | |
| Spearman Rank Test | 0.74 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Arbutus Biopharma Corp lagged returns against current returns
Autocorrelation, which is Arbutus Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Arbutus Biopharma's stock expected returns. We can calculate the autocorrelation of Arbutus Biopharma returns to help us make a trade decision. For example, suppose you find that Arbutus Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Arbutus Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Arbutus Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Arbutus Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Arbutus Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Arbutus Biopharma Lagged Returns
When evaluating Arbutus Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Arbutus Biopharma stock have on its future price. Arbutus Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Arbutus Biopharma autocorrelation shows the relationship between Arbutus Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Arbutus Biopharma Corp.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.